We are Pharmacosmos Therapeutics.

We want to change the way iron deficiency anemia is treated, and chemotherapy-induced myelosuppression is prevented.

Explore Pharmacosmos
Pharmacosmos Therapeutics Inc is...

A leader in providing innovative treatments for unmet patient needs, with a focus on iron metabolism and blood related disorders.

Who we are

As a family-held company, we are cognizant of how work shapes who we are and who we aspire to become.

Our science

Building on our foundational expertise in carbohydrate chemistry and cell cycle biology, we develop innovative treatments for unmet patient needs with a focus on iron metabolism and blood-related disorders.

Clinical trials

We are developing petadeferitrin, a novel iron chelator, as a new treatment for patients with transfusional iron overload.

Life at Pharmacosmos Therapeutics

We prioritize ensuring an inclusive and appreciative culture that helps us connect better as a team. Bringing together diverse perspectives allows us to continuously collaborate and innovate.

Career

We have many exciting opportunities ahead of us. Do you want to join us?

News

Stay informed about what’s happening at Pharmacosmos Therapeutics Inc.

Global presence

Our global presence is strong due to our Denmark-based parent company, Pharmacosmos A/S, as well as our skilled colleagues and partners in all major pharmaceutical markets. Today, Pharmacosmos products are represented in more than 40 countries. This is the key to our accelerated growth and will lay the foundation for future regional and global innovations and partnerships.

Join us on Linkedin

Get exclusive updates, expert insights, and career offers